The patient with a thyroid nodule

Medical Clinics of North America

Volumn 94, Issue 5, 2010, Pages 1003-1015

  Miller, Matthew C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Fine needle aspiration; Incidentaloma; Thyroid nodule; Thyroidectomy

Indexed keywords

CALCITONIN; FLUORODEOXYGLUCOSE F 18; THYROTROPIN;

AGE DISTRIBUTION; CALCITONIN BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FAMILY HISTORY; FOLLOW UP; GOLD STANDARD; HUMAN; MEDICAL SPECIALIST; MULTIPARA; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PATIENT REFERRAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; THYROID CARCINOMA; THYROID INCIDENTALOMA; THYROID NODULE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; ULTRASOUND;

BIOPSY, FINE-NEEDLE; HUMANS; HYPOTHYROIDISM; INCIDENTAL FINDINGS; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 77955878084     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.05.001     Document Type: Review

References (78)

1. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
2. Knudsen K., Laurberg P., Perrild H., et al. Risk factors for goiter and thyroid nodules. Thyroid 2002, 12(10):879-888.
3. Ezzat S., Sarti D.A., Cain D.R., et al. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med 1994, 154:1838-1840.
4. Galanti M.R., Granath F., Cnattingius S., et al. Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. J Intern Med 2005, 258(3):257-264.
5. Cibas E.S., Alexander E.K., Benson C.B., et al. Indications for thyroid FNA and pre-FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36(6):390-399.
6. Antonelli A., Silvano G., Bianchi F., et al. Risk of thyroid nodules in subjects occupationally exposed to radiation: a cross sectional study. Occup Environ Med 1995, 52(8):500-504.
7. Kung A.W., Chau M.T., Lao T.T., et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002, 87(3):1010-1014.
8. Struve C.W., Haupt S., Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 1993, 3(1):7-10.
9. Spinos N., Terzis G., Crysanthopoulou A., et al. Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids. Thyroid 2007, 17(12):1257-1259.
10. Wang C., Crapo L.M. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997, 26(1):189-218.
11. Tan G.H., Gharib H., Reading C.C. Solitary thyroid nodule: comparison between palpation and ultrasonography. Arch Intern Med 1995, 155:2418-2423.
12. Brander A., Viikinkoski P., Nickels J., et al. Thyroid gland: US screening in a random adult population. Radiology 1991, 181:683-687.
13. Brander A., Viikinkoski P., Nickels J., et al. Thyroid gland: US screening in middle-aged women with no previous thyroid disease. Radiology 1989, 173:507-510.
14. Guth S., Theune U., Aberle J., et al. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009, 39(8):699-706.
15. Gharib H., Papini E., Valcavi R., et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006, 12(1):63-102.
16. Baloch Z.W., Cibas E.S., Clark D.P., et al. The National Cancer Institute thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 2008, 5(6):1-17.
17. Kovacs G.L., Ganda G., Vadasz G., et al. Epidemiology of thyroid microcarcinoma found in autopsy series found in areas of different iodine uptake. Thyroid 2005, 15(2):152-157.
18. de Matos P.S., Ferreira A.P., Ward L.S. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol 2006, 17(2):165-173.
19. Yamamoto Y., Maeda T., Izumi K., et al. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990, 65(5):1173-1179.
20. Pazaitou-Panayiotou K., Capezzone M., Pacini F. Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 2007, 17(11):1085-1092.
21. Sugitani I., Toda K., Yamada K., et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010, 34(6):1222-1231.
22. Kim E.W., Lee E.J., Kim S.H., et al. Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules: comparison of efficacy according to nodule size. Thyroid 2009, 19(1):27-31.
23. Leenhardt L., Hejblum G., Franc B., et al. Indications and limits of ultrasound-guided cytology in the management of non-palpable thyroid nodules. J Clin Endocrinol Metab 1999, 84:24-28.
24. Steele S.R., Martin M.J., Mullenix P.S., et al. The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg 2005, 140:981-985.
25. Yoon D.W., Chang S.K., Choi C.S., et al. The prevalence and significance of incidental thyroid nodules identified on computed tomography. J Comput Assist Tomogr 2008, 32:810-815.
26. Shetty S.K., Maher M.M., Hahn P.F., et al. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 2006, 187:1349-1356.
27. Yousem D.M., Huang T., Loevner L.A., et al. Clinical and economic impact of incidental thyroid lesions found with CT and MR. AJNR Am J Neuroradiol 1997, 18:1423-1428.
28. Chen Y.K., Ding H.J., Chen K.T., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005, 25(2B):1421-1426.
29. Kim T.Y., Kim W.B., Ryu J.S., et al. 18F-Fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005, 115:1074-1078.
30. Shie P., Cardarelli R., Sprawls K., et al. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2009, 30(9):742-748.
31. Liu Y. Clinical significance of thyroid uptake on F18-fl uorodeoxyglucose positron emission tomography. Ann Nucl Med 2009, 23:17-23.
32. Dal Maso L., Bosetti C., La Vecchia C., et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009, 20(1):75-86.
33. Taylor A.J., Croft A.P., Palace A.M., et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 2009, 125(10):2400-2405.
34. Perrier N.D., Ituarte P., Siperstein A.E., et al. Latency period of thyroid neoplasia after radiation exposure. Ann Surg 2004, 239(4):536-543.
35. Schneider A.B., Ron E., Lubin J., et al. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993, 77(2):362-369.
36. Hemminki K., Eng C., Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005, 90(10):5747-5753.
37. Hemminki K., Dong C. Familial relationships in thyroid cancer by histo-pathological type. Int J Cancer 2000, 85(2):201-205.
38. Raza S.N., Shah M.D., Palme C.E., et al. Risk factors for well-differentiated thyroid carcinoma in patients with thyroid nodular disease. Otolaryngol Head Neck Surg 2008, 139(1):21-26.
39. Randolph G.W., Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006, 139:357-362.
40. Polyzos S.A., Kita M., Efstathiadou Z., et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 2008, 134(9):953-960.
41. Boelaert K., Horacek J., Holder R.L., et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006, 91(11):4295-4301.
42. Fiore E., Rago T., Provenzale M.A., et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009, 16(4):1251-1260.
43. Meller J., Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med 2002, 29(Suppl 2):S425-S438.
44. Wilhelm S.M. Utility of I-123 thyroid uptake scan in incidental thyroid nodules: an old test with a new role. Surgery 2008, 144(4):511-515.
45. Jimenez C., Hu M.I., Gagel R.F. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 2008, 37:481-496.
46. Forrest C.H., Frost F.A., de Boer W.B., et al. Medullary carcinoma of the thyroid: accuracy of diagnosis by fine-needle aspiration cytology. Cancer Cytopathol 1998, 84:295-302.
47. Hahm J.R., Lee M.S., Min Y.K., et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001, 11(1):73-80.
48. Cheung K., Roman S.A., Wang T.S., et al. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008, 93(6):2173-2180.
49. Wang N., Xu Y., Ge C., et al. Association of sonographically detected calcification with thyroid carcinoma. Head Neck 2006, 28(12):1077-1083.
50. Frates M.C., Benson C.B., Doubilet P.M., et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006, 91(9):3411-3417.
51. Tae H.J., Lim D.J., Baek K.H., et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 2007, 17(5):461-466.
52. Alexander E.K., Marqusee E., Orcutt J., et al. Thyroid nodule shape and prediction of malignancy. Thyroid 2004, 14(11):953-958.
53. Ahn S.S., Kim E.K., Kang D.R., et al. Biopsy of thyroid nodules: comparison of three sets of guidelines. AJR Am J Roentgenol 2010, 194(1):31-37.
54. McCoy K.L., Jabbour N., Ogilvie J.B., et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery 2007, 142(6):837-844.
55. Frates M.C., Benson C.B., Charboneau J.W., et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005, 237(3):794-800.
56. Pitman M.B., Abele J., Ali S.Z., et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36(6):407-424.
57. Gandolfi P.P., Frisina A., Raffa M., et al. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed 2004, 75:114-117.
58. Zhu W., Michael C.W. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases. Diagn Cytopathol 2007, 35(3):183-186.
59. Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 1996, 15(1):84-89.
60. Oertel Y.C., Felipe L.M., Mendoza M.G., et al. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid 2007, 17(11):1061-1066.
61. Yang J., Schnadig V., Logrono R., et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer Cytopathol 2007, 111:306-315.
62. Orlandi A., Puscar A., Capriata E., et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow up. Thyroid 2005, 15(3):274-278.
63. Sdano M.T., Falciglia M., Welge J.A., et al. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 2005, 133:391-396.
64. Bennedbaek F.N., Nielsen L.K., Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab 1998, 83(3):830-835.
65. Papini E., Guglielmi R., Bizzarri G., et al. Treatment of benign cold nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroixine therapy or follow-up. Thyroid 2007, 17(3):229-235.
66. Mihai R., Parker A.J., Roskell D., et al. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid 2009, 19(1):33-37.
67. Raparia K., Min S.K., Mody D.R., et al. Clinical outcomes for " suspicious" category in thyroid fine-needle aspiration biopsy: patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009, 133(5):787-790.
68. Goldstein R.E., Netterville J.L., Burkey B., et al. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002, 235(5):656-662.
69. Gal I., Solymosi T., Szabo Z., et al. Minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: a prospective randomized study. Surg Endosc 2008, 22:2445-2449.
70. Cavicchi O., Piccin O., Ceroni A.R., et al. Minimally invasive nonendoscopic thyroidectomy. Otolaryngol Head Neck Surg 2006, 135(5):744-747.
71. Kang S.W., Lee S.C., Lee S.H., et al. Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery 2009, 146(6):1048-1055.
72. Sosa J.A., Bowman H.M., Tielsch J.M., et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998, 228(3):320-330.
73. Miller M.C., Spiegel J.R. Identification and monitoring of the recurrent laryngeal nerve during thyroidectomy. Surg Oncol Clin N Am 2008, 17(1):121-144.
74. Fewins J., Simpson C.B., Miller F.R. Complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am 2003, 36:189-206.
75. Nikiforov Y.E., Steward D.L., Robinson-Smith T.M., et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009, 94(6):2092-2098.
76. Bartolazzi A., Orlandi F., Saggiorato E., et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 2008, 9(6):543-549.
77. Bentz B.G., Miller B.T., Holden J.A., et al. B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules. Otolaryngol Head Neck Surg 2009, 140:709-714.
78. Lubitz C.C., Ugrass S.K., Kazam J.J., et al. Microarray analysis of thyroid fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn 2006, 8:490-498.